Emerg Med Clin North Am. 1996 Nov;14(4):757-88. doi: 10.1016/s0733-8627(05)70278-9.
PMID:8921768
Improving the outcome of fistulising Crohn's disease.
Molendijk I, Peeters KC, Baeten CI, Veenendaal RA, van der Meulen-de Jong AE.
Best Pract Res Clin Gastroenterol. 2014 Jun;28(3):505-18. doi: 10.1016/j.bpg.2014.04.011. Epub 2014 May 5.
PMID:24913389
An Integrative analysis of single-cell RNA-seq, transcriptome and Mendelian randomization for the Identification and validation of NAD(+) Metabolism-Related biomarkers in ulcerative colitis.
Zhang L, Li J, Zhang Q, Gao J, Zhao K, Asai Y, Hu Z, Gao H.
Int Immunopharmacol. 2025 Jan 3;145:113765. doi: 10.1016/j.intimp.2024.113765. Epub 2024 Dec 7.
PMID:39647286
Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation.
Hardt J, Meerpohl JJ, Metzendorf MI, Kienle P, Post S, Herrle F.
Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study).
Herreros MD, Ramirez JM, Otero-Piñeiro AM, Martí-Gallostra M, Badiola I, Enríquez-Navascues JM, Millan M, Barreiro EM, De La Portilla F, Suárez Alecha J, García-Olmo D; National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn’s Fistula (the PRIME Study) Group.